{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:07:38Z","timestamp":1793412458802,"version":"4.5.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>A 5-year-old child with tuberculous meningoencephalitis developed severe drug-induced hepatitis after conventional antitubercular therapy. Consequently, standard treatment was discontinued, and second-line drugs were administered in combination with high-dose corticosteroids. However, the disease continued to progress significantly. The introduction of infliximab resulted in substantial clinical and radiologic improvement, highlighting its potential role in managing refractory cases of central nervous system tuberculosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000005253","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T16:01:31Z","timestamp":1777910491000},"page":"894-898","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Infliximab in a Child With Relapsing Tuberculous Meningoencephalitis"],"prefix":"10.1097","volume":"45","author":[{"given":"Chiara","family":"Barone","sequence":"first","affiliation":[{"name":"Area Pediatrica, Dipartimento di Scienze della Vita e Sanit\u00e0 Pubblica, Universit\u00e0 Cattolica del Sacro Cuore, Roma, Italia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Capitani","sequence":"additional","affiliation":[{"name":"Medicine and Sugery, Universit\u00e0 Cattolica del Sacro Cuore, Roma, Italia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Fresch","sequence":"additional","affiliation":[{"name":"Area Pediatrica, Dipartimento di Scienze della Vita e Sanit\u00e0 Pubblica, Universit\u00e0 Cattolica del Sacro Cuore, Roma, Italia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Veredice","sequence":"additional","affiliation":[{"name":"Child Neurology and Psychiatry Unit, Department of Neuroscience, Universit\u00e0 Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Piastra","sequence":"additional","affiliation":[{"name":"Paediatric Intensive Care Unit and Trauma Centre, Universit\u00e0 Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Frassanito","sequence":"additional","affiliation":[{"name":"Pediatric Neurosurgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Onesimo","sequence":"additional","affiliation":[{"name":"Area Pediatrica, Dipartimento di Scienze della Vita e Sanit\u00e0 Pubblica, Universit\u00e0 Cattolica del Sacro Cuore, Roma, Italia"},{"name":"Child Neurology and Psychiatry Unit, Department of Neuroscience, Universit\u00e0 Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8567-2639","authenticated-orcid":false,"given":"Danilo","family":"Buonsenso","sequence":"additional","affiliation":[{"name":"Area Pediatrica, Dipartimento di Scienze della Vita e Sanit\u00e0 Pubblica, Universit\u00e0 Cattolica del Sacro Cuore, Roma, Italia"},{"name":"Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"key":"R2-20260911","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMra1008049","article-title":"Tuberculosis in children.","volume":"367","author":"Perez-Velez","year":"2012","journal-title":"N Engl J Med"},{"key":"R3-20260911","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.mpmed.2017.08.010","article-title":"Tuberculous meningitis.","volume":"45","author":"Thwaites","year":"2013","journal-title":"Medicine (Baltimore)"},{"key":"R4-20260911","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jns.2014.03.025","article-title":"Paradoxical reaction in HIV negative tuberculous meningitis.","volume":"340","author":"Garg","year":"2014","journal-title":"J Neurol Sci"},{"key":"R5-20260911","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12879-016-1625-9","article-title":"Paradoxical reaction in tuberculous meningitis: presentation, predictors and impact on prognosis.","volume":"16","author":"Singh","year":"2016","journal-title":"BMC Infect Dis"},{"key":"R6-20260911","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1473-3099(13)70031-8","article-title":"Progress and challenges in childhood tuberculosis.","volume":"13","author":"Marais","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"R7-20260911","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1016\/S1473-3099(23)00004-X","article-title":"Post-tuberculosis sequelae in children and adolescents: a systematic review.","volume":"23","author":"Igbokwe","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"R8-20260911","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/cid\/ciab982","article-title":"Treatment and outcome in children with tuberculous meningitis: a multicenter pediatric tuberculosis network European trials group study.","volume":"75","author":"Thee","year":"2022","journal-title":"Clin Infect Dis"},{"key":"R9-20260911","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.2008-1353","article-title":"Twenty years of pediatric tuberculous meningitis: a retrospective cohort study in the Western Cape of South Africa.","volume":"123","author":"Van Well","year":"2009","journal-title":"Pediatrics"},{"key":"R10-20260911","doi-asserted-by":"crossref","first-page":"e0133477","DOI":"10.1371\/journal.pone.0133477","article-title":"Tuberculous meningitis in children and adults: a 10-year retrospective comparative analysis.","volume":"10","author":"Miftode","year":"2015","journal-title":"PLoS One"},{"key":"R11-20260911","doi-asserted-by":"crossref","first-page":"220","DOI":"10.18203\/2394-6040.ijcmph20164742","article-title":"Outcome of children with tuberculous meningitis: a prospective study from a tertiary care centre in Southern India.","volume":"4","author":"Mohan","year":"2016","journal-title":"Int J Community Med Public Health"},{"key":"R12-20260911","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/clinids\/21.4.924","article-title":"Concentrations of interferon gamma, tumor necrosis factor alpha, and interleukin-1 beta in the cerebrospinal fluid of children treated for tuberculous meningitis.","volume":"21","author":"Donald","year":"1995","journal-title":"Clin Infect Dis"},{"key":"R13-20260911","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/cid\/cix540","article-title":"Biomarkers of cerebral injury and inflammation in pediatric tuberculous meningitis.","volume":"65","author":"Rohlwink","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R14-20260911","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1073\/pnas.96.10.5657","article-title":"Tumor necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system.","volume":"96","author":"Tsenova","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R15-20260911","doi-asserted-by":"crossref","first-page":"e11186","DOI":"10.1097\/MD.0000000000011186","article-title":"Intracranial tuberculous mass lesions treated with thalidomide in an immunocompetent child from a low tuberculosis endemic country: a case report.","volume":"97","author":"Caraffa","year":"2018","journal-title":"Medicine (Baltim)"},{"key":"R16-20260911","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1177\/0883073809350507","article-title":"Tuberculous meningitis-related optic neuritis: recovery of vision with thalidomide in 4 consecutive cases.","volume":"25","author":"Schoeman","year":"2010","journal-title":"J Child Neurol"},{"key":"R17-20260911","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/WNF.0b013e318285caa1","article-title":"Clinical response to thalidomide in the treatment of intracranial tuberculomas: case report.","volume":"36","author":"De la Riva","year":"2013","journal-title":"Clin Neuropharmacol"},{"key":"R18-20260911","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1212\/WNL.0000000000013047","article-title":"Infliximab to treat severe paradoxical reaction in HIV-negative tuberculous meningoencephalitis.","volume":"98","author":"Goulenok","year":"2022","journal-title":"Neurology"},{"key":"R19-20260911","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3988\/jcn.2023.0290","article-title":"Infliximab for intractable paradoxical reaction in culture-negative tuberculosis meningitis.","volume":"20","author":"Kim","year":"2024","journal-title":"J Clin Neurol"},{"key":"R20-20260911","first-page":"004822","article-title":"Paradoxical deterioration during treatment of tuberculous meningitis responded to infliximab but not to steroids.","volume":"11","author":"Husic","year":"2024","journal-title":"Eur J Case Rep Intern Med"},{"key":"R21-20260911","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1097\/INF.0000000000002578","article-title":"Successful treatment of a severe vision-threatening paradoxical tuberculous reaction with infliximab: first pediatric use.","volume":"39","author":"Abo","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"R22-20260911","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/jpids\/piab094","article-title":"Infliximab for paradoxical reactions in pediatric central nervous system tuberculosis.","volume":"10","author":"Abo","year":"2021","journal-title":"J Pediatric Infect Dis Soc"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005253","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:00:46Z","timestamp":1789099246000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005253"}},"subtitle":["A Case Report and Literature Review"],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000005253","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]}}}